Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Biochemistry

Background:

• Statins (HMG-CoA reductase inhibitors) are proven to prevent coronary heart disease (CHD) primarily through low-density lipoprotein cholesterol (LDL-C) reduction.
• Statins exhibit varying effects on high-density lipoprotein cholesterol (HDL-C) levels, suggesting mechanisms beyond LDL-C lowering.

Purpose of the Study:

• To elucidate the molecular mechanisms by which statins elevate HDL-C.
• To explore the impact of statin-induced HDL-C elevation on HDL functions.
• To review the effects of statins on proteins, enzymes, and receptors involved in reverse cholesterol transport (RCT).

Main Methods:

• Literature review and summary of existing research on statin mechanisms.
• Analysis of studies investigating statin effects on apolipoprotein A-I (ApoA-I) synthesis and HDL neogenesis.
• Examination of statin impact on RCT pathways and HDL-associated proteins.

Main Results:

• Statins increase hepatic synthesis of apolipoprotein A-I (ApoA-I) and promote HDL neogenesis.
• These effects suggest that statin-mediated HDL-C elevation is linked to the activation of reverse cholesterol transport (RCT).
• HDL possesses pleiotropic functions, including anti-inflammatory and anti-oxidative properties, in addition to its role in RCT.

Conclusions:

• Statin-induced HDL-C elevation may signify enhanced RCT, a protective mechanism against atherosclerosis.
• The functional assessment of statin-modified HDL is crucial for future clinical applications.
• Personalized statin selection based on differential HDL-modulating effects may be warranted in clinical practice.